prices, quantities, and times, resulting in matched trades among themselves. They also submitted buy orders at multiple price levels to obstruct other investors and push the price of AKP shares upward
compared to total revenue from medical treatment for the fiscal year 2018 and 2019, equaled to 70.5% and 81.4% respectively. The major proportion in cost of medical treatments were derived from cost incurred
million Baht. From better performance in Q2/2017 it made the Company and its subsidiaries had total revenue for the six months ended June 30, 2017 equaled to 434.33 million Baht, an increase of 221.12
with total revenue from medical treatment for the 1st quarter of Year 2019, equaled to 78.4% comparing to the 1st quarter of Year 2018, equaled to 63.3%. There are two main reasons of the increasing in
March 2019, the company’s gross profit equaled THB 188.31 million or 65.65%, which were lower than 67.57% in Quarter 1/ 2018. The factor was higher take-home products and larger OEM volume which yield
capital budget, in amount of Baht 133,583,482 comparing to the previous one in amount of Baht 425,000,000. Therefore, total investment equaled to Baht 558,583,482. This expansion of Wattanapat Samui
time at the same or similar prices and/or volumes, and matched the BM share trading orders in large volumes on four business days on 2 February 2018 and 6, 12 and 13 March 2018. Their actions misled
% from 185 Rajdamri, total of 6 projects. Cost of Sales In 1Q/19 the Company’s real estate business cost equaled THB 989.3mn, an increase of THB 589.5mn from THB 399.8mn YoY. Cost of food and beverages
Samui Hospital project will finally be increased in total capital budget, in amount of Baht 133,583,482 comparing to the previous one in amount of Baht 425,000,000. Therefore, total investment equaled to